Clin2
NCT07040046Likely a fitRecruiting

Study of HS-10542 in healthy volunteers

Healthy

This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
100 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old.
  • Your BMI is between 19 and 28, and you weigh at least 50 kg (men) or 45 kg (women).
  • You can get the required vaccines (against meningitis and pneumonia) at least two weeks before the first dose.
  • You agree to use effective birth control: women from 2 weeks before screening until 60 days after the last dose, men from signing consent until 120 days after the last dose.
  • You have no serious health problems that would make the study unsafe, and you can follow the study rules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07483437Not yet recruiting· Phase 1
Study of HS-20136-2 in healthy people

This study tests a new medicine called HS-20136-2 in healthy volunteers. It aims to see how safe the medicine is and how the body processes it.

Adelaide, South Australia
NCT06612970Recruiting· Phase 1
Single dose study of HB0056 in healthy adults

This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.

Christchurch
NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai
NCT07503015Not yet recruiting· Phase 1
Testing HS-20152 in healthy volunteers

This study tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. It is an early-phase trial, so it helps find the right dose and check for side effects.

Qingdao, Shandong
NCT07770217Not yet recruiting· Phase 1
Study of a new drug for healthy adults

This trial tests a new drug called HS-10504 in healthy adults to see how the body processes it. It is an early-phase study that helps determine safe dosing.

NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.